About
Two intestinal disorders fall into the category of inflammatory bowel diseases. These diseases are Crohn’s disease and ulcerative colitis. As the name suggests, these conditions result in chronic inflammation and show symptoms such as severe abdominal pain, diarrhea, and rectal bleeding. In Crohn’s disease, the inflammation can be anywhere in the GI tract, and it can extend through the thickness of the bowel. It can occur in several small patches or one large patch.
The exact reason for inflammatory bowel disease is unknown, but research evidence suggests that environmental factors, immune dysregulation, intestinal microorganisms, and genetic predisposition may be the culprits.
A recent study explored the link between IBD and anxiety by taking into consideration many studies that suggest that patients with IBD experienced psychological comorbidities. Another study explains abnormal levels of anxiety in 40% of IBD patients. Research scientists say that the prevalence of anxiety is much higher than expected in patients with Crohn’s disease. The severity of symptoms is another factor that can contribute to developing anxiety.
Other studies suggest that the prevalence of anxiety may flare up the severity of IBD. One study found out the link between active mucosal inflammation and psychological symptoms. This research has been helpful because it tells the importance of preventing and treating inflammation. IBD patients who are successful in keeping inflammation at bay are also successful in reducing anxiety considerably.
It may be worth mentioning here that the patients who are at the highest risk of developing anxiety are the ones with an ostomy. Ostomy patients commonly have decreased quality of life and more psychological issues. What’s unfortunate is that they do not receive the psychological help they need.
A recent study explored the link between IBD and anxiety by taking into consideration many studies that suggest that patients with IBD experienced psychological comorbidities. Another study explains abnormal levels of anxiety in 40% of IBD patients. Research scientists say that the prevalence of anxiety is much higher than expected in patients with Crohn’s disease. The severity of symptoms is another factor that can contribute to developing anxiety.
Other studies suggest that the prevalence of anxiety may flare up the severity of IBD. One study found out the link between active mucosal inflammation and psychological symptoms. This research has been helpful because it tells the importance of preventing and treating inflammation. IBD patients who are successful in keeping inflammation at bay are also successful in reducing anxiety considerably.
It may be worth mentioning here that the patients who are at the highest risk of developing anxiety are the ones with an ostomy. Ostomy patients commonly have decreased quality of life and more psychological issues. What’s unfortunate is that they do not receive the psychological help they need.
What is an ostomy?
An ostomy is a surgical opening to eliminate bodily waste, bypassing the natural excretory pathway. People get it when they develop a problem that causes their digestive system to cease to function properly. This problem may be a medical condition or an injury. An ostomy bypasses the diseased part of the colon and reroutes the stool towards the stoma, which is a surgically created opening in the abdomen. A stoma is the end of the active segment of the colon if it is the case of a colostomy.
Treating IBD and anxiety
Generally, IBD is the root cause that results in anxiety and other disorders related to digestion and intestinal functions. It means that treating IBD should also treat anxiety to a significant extent. In many cases, counseling may be required to treat anxiety resulting from IBD.
Generally, IBD is the root cause that results in anxiety and other disorders related to digestion and intestinal functions. It means that treating IBD should also treat anxiety to a significant extent. In many cases, counseling may be required to treat anxiety resulting from IBD.